Summary

The global mRNA Flu Vaccine market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
In 2025, the North America mRNA Flu Vaccine market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of mRNA Flu Vaccine include Moderna, BioNTech, Sanofi, Curevac, Pfizer, Arcturus Therapeutics Holdings, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global mRNA Flu Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Moderna
BioNTech
Sanofi
Curevac
Pfizer
Arcturus Therapeutics Holdings
Segment by Type
mRNA-1010
mRNA-1020
mRNA-1030
Segment by Application
Hospital
Clinic
Other
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of mRNA Flu Vaccine market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the mRNA Flu Vaccine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 mRNA-1010
1.2.3 mRNA-1020
1.2.4 mRNA-1030
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global mRNA Flu Vaccine Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global mRNA Flu Vaccine Market Share by Revenue, by Region (2021-2026)
2.4 Global mRNA Flu Vaccine Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America mRNA Flu Vaccine Market Size and Prospective (2021-2032)
2.5.2 Europe mRNA Flu Vaccine Market Size and Prospective (2021-2032)
2.5.3 China mRNA Flu Vaccine Market Size and Prospective (2021-2032)
2.5.4 Japan mRNA Flu Vaccine Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global mRNA Flu Vaccine Historical Market Size by Type (2021-2026)
3.2 Global mRNA Flu Vaccine Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of mRNA Flu Vaccine

4 Breakdown Data by Application
4.1 Global mRNA Flu Vaccine Historical Market Size by Application (2021-2026)
4.2 Global mRNA Flu Vaccine Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in mRNA Flu Vaccine Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top mRNA Flu Vaccine Players by Revenue (2021-2026)
5.1.2 Global mRNA Flu Vaccine Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by mRNA Flu Vaccine Revenue
5.4 Global mRNA Flu Vaccine Market Concentration Analysis
5.4.1 Global mRNA Flu Vaccine Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by mRNA Flu Vaccine Revenue in 2025
5.5 Global Key Players of mRNA Flu Vaccine Head Offices and Areas Served
5.6 Global Key Players of mRNA Flu Vaccine, Product and Application
5.7 Global Key Players of mRNA Flu Vaccine, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America mRNA Flu Vaccine Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America mRNA Flu Vaccine Market Size by Type (2021-2026)
6.1.2.2 North America mRNA Flu Vaccine Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America mRNA Flu Vaccine Market Size by Application (2021-2026)
6.1.3.2 North America mRNA Flu Vaccine Market Share by Application (2021-2026)
6.1.4 North America mRNA Flu Vaccine Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe mRNA Flu Vaccine Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe mRNA Flu Vaccine Market Size by Type (2021-2026)
6.2.2.2 Europe mRNA Flu Vaccine Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe mRNA Flu Vaccine Market Size by Application (2021-2026)
6.2.3.2 Europe mRNA Flu Vaccine Market Share by Application (2021-2026)
6.2.4 Europe mRNA Flu Vaccine Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China mRNA Flu Vaccine Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China mRNA Flu Vaccine Market Size by Type (2021-2026)
6.3.2.2 China mRNA Flu Vaccine Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China mRNA Flu Vaccine Market Size by Application (2021-2026)
6.3.3.2 China mRNA Flu Vaccine Market Share by Application (2021-2026)
6.3.4 China mRNA Flu Vaccine Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan mRNA Flu Vaccine Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan mRNA Flu Vaccine Market Size by Type (2021-2026)
6.4.2.2 Japan mRNA Flu Vaccine Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan mRNA Flu Vaccine Market Size by Application (2021-2026)
6.4.3.2 Japan mRNA Flu Vaccine Market Share by Application (2021-2026)
6.4.4 Japan mRNA Flu Vaccine Major Customers
6.4.5 Japan Market Trends and Opportunities

7 Key Player Profiles
7.1 Moderna
7.1.1 Moderna Company Details
7.1.2 Moderna Business Overview
7.1.3 Moderna mRNA Flu Vaccine Introduction
7.1.4 Moderna Revenue in mRNA Flu Vaccine Business (2021-2026)
7.1.5 Moderna Recent Development
7.2 BioNTech
7.2.1 BioNTech Company Details
7.2.2 BioNTech Business Overview
7.2.3 BioNTech mRNA Flu Vaccine Introduction
7.2.4 BioNTech Revenue in mRNA Flu Vaccine Business (2021-2026)
7.2.5 BioNTech Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Details
7.3.2 Sanofi Business Overview
7.3.3 Sanofi mRNA Flu Vaccine Introduction
7.3.4 Sanofi Revenue in mRNA Flu Vaccine Business (2021-2026)
7.3.5 Sanofi Recent Development
7.4 Curevac
7.4.1 Curevac Company Details
7.4.2 Curevac Business Overview
7.4.3 Curevac mRNA Flu Vaccine Introduction
7.4.4 Curevac Revenue in mRNA Flu Vaccine Business (2021-2026)
7.4.5 Curevac Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Details
7.5.2 Pfizer Business Overview
7.5.3 Pfizer mRNA Flu Vaccine Introduction
7.5.4 Pfizer Revenue in mRNA Flu Vaccine Business (2021-2026)
7.5.5 Pfizer Recent Development
7.6 Arcturus Therapeutics Holdings
7.6.1 Arcturus Therapeutics Holdings Company Details
7.6.2 Arcturus Therapeutics Holdings Business Overview
7.6.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Introduction
7.6.4 Arcturus Therapeutics Holdings Revenue in mRNA Flu Vaccine Business (2021-2026)
7.6.5 Arcturus Therapeutics Holdings Recent Development

8 mRNA Flu Vaccine Market Dynamics
8.1 mRNA Flu Vaccine Industry Trends
8.2 mRNA Flu Vaccine Market Drivers
8.3 mRNA Flu Vaccine Market Challenges
8.4 mRNA Flu Vaccine Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global mRNA Flu Vaccine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global mRNA Flu Vaccine Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market mRNA Flu Vaccine Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global mRNA Flu Vaccine Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global mRNA Flu Vaccine Revenue Share by Region (2021-2026)
Table 6. Global mRNA Flu Vaccine Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global mRNA Flu Vaccine Revenue Share Forecast by Region (2027-2032)
Table 8. Global mRNA Flu Vaccine Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global mRNA Flu Vaccine Market Share by Revenue, by Type (2021-2026)
Table 10. Global mRNA Flu Vaccine Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global mRNA Flu Vaccine Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global mRNA Flu Vaccine Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global mRNA Flu Vaccine Market Share by Revenue, by Application (2021-2026)
Table 15. Global mRNA Flu Vaccine Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global mRNA Flu Vaccine Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in mRNA Flu Vaccine Applications
Table 18. Global mRNA Flu Vaccine Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global mRNA Flu Vaccine Market Share by Players (2021-2026)
Table 20. Global Top mRNA Flu Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Flu Vaccine as of 2025)
Table 21. Ranking of Global Top mRNA Flu Vaccine Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by mRNA Flu Vaccine Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of mRNA Flu Vaccine, Headquarters and Area Served
Table 24. Global Key Players of mRNA Flu Vaccine, Product and Application
Table 25. Global Key Players of mRNA Flu Vaccine, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America mRNA Flu Vaccine Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America mRNA Flu Vaccine Market Share by Revenue, by Company (2021-2026)
Table 29. North America mRNA Flu Vaccine Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America mRNA Flu Vaccine Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe mRNA Flu Vaccine Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe mRNA Flu Vaccine Market Share by Revenue, by Company (2021-2026)
Table 33. Europe mRNA Flu Vaccine Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe mRNA Flu Vaccine Market Size by Application (2021-2026) & (US$ Million)
Table 35. China mRNA Flu Vaccine Revenue by Company (2021-2026) & (US$ Million)
Table 36. China mRNA Flu Vaccine Market Share by Revenue, by Company (2021-2026)
Table 37. China mRNA Flu Vaccine Market Size by Type (2021-2026) & (US$ Million)
Table 38. China mRNA Flu Vaccine Market Size by Application (2021-2026) & (US$ Million)
Table 39. Japan mRNA Flu Vaccine Revenue by Company (2021-2026) & (US$ Million)
Table 40. Japan mRNA Flu Vaccine Market Share by Revenue, by Company (2021-2026)
Table 41. Japan mRNA Flu Vaccine Market Size by Type (2021-2026) & (US$ Million)
Table 42. Japan mRNA Flu Vaccine Market Size by Application (2021-2026) & (US$ Million)
Table 43. Moderna Company Details
Table 44. Moderna Business Overview
Table 45. Moderna mRNA Flu Vaccine Product
Table 46. Moderna Revenue in mRNA Flu Vaccine Business (2021-2026) & (US$ Million)
Table 47. Moderna Recent Development
Table 48. BioNTech Company Details
Table 49. BioNTech Business Overview
Table 50. BioNTech mRNA Flu Vaccine Product
Table 51. BioNTech Revenue in mRNA Flu Vaccine Business (2021-2026) & (US$ Million)
Table 52. BioNTech Recent Development
Table 53. Sanofi Company Details
Table 54. Sanofi Business Overview
Table 55. Sanofi mRNA Flu Vaccine Product
Table 56. Sanofi Revenue in mRNA Flu Vaccine Business (2021-2026) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. Curevac Company Details
Table 59. Curevac Business Overview
Table 60. Curevac mRNA Flu Vaccine Product
Table 61. Curevac Revenue in mRNA Flu Vaccine Business (2021-2026) & (US$ Million)
Table 62. Curevac Recent Development
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer mRNA Flu Vaccine Product
Table 66. Pfizer Revenue in mRNA Flu Vaccine Business (2021-2026) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Arcturus Therapeutics Holdings Company Details
Table 69. Arcturus Therapeutics Holdings Business Overview
Table 70. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product
Table 71. Arcturus Therapeutics Holdings Revenue in mRNA Flu Vaccine Business (2021-2026) & (US$ Million)
Table 72. Arcturus Therapeutics Holdings Recent Development
Table 73. mRNA Flu Vaccine Market Trends
Table 74. mRNA Flu Vaccine Market Drivers
Table 75. mRNA Flu Vaccine Market Challenges
Table 76. mRNA Flu Vaccine Market Restraints
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources

List of Figures
Figure 1. mRNA Flu Vaccine Product Picture
Figure 2. Global mRNA Flu Vaccine Market Share by Type: 2025 vs 2032
Figure 3. mRNA-1010 Features
Figure 4. mRNA-1020 Features
Figure 5. mRNA-1030 Features
Figure 6. Global mRNA Flu Vaccine Market Share by Application: 2025 vs 2032
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. mRNA Flu Vaccine Report Years Considered
Figure 11. Global mRNA Flu Vaccine Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global mRNA Flu Vaccine Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global mRNA Flu Vaccine Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America mRNA Flu Vaccine Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe mRNA Flu Vaccine Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. China mRNA Flu Vaccine Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Japan mRNA Flu Vaccine Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global mRNA Flu Vaccine Market Share by Players in 2025
Figure 19. Global Top mRNA Flu Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Flu Vaccine as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by mRNA Flu Vaccine Revenue in 2025
Figure 21. North America mRNA Flu Vaccine Market Share by Type (2021-2026)
Figure 22. North America mRNA Flu Vaccine Market Share by Application (2021-2026)
Figure 23. Europe mRNA Flu Vaccine Market Share by Type (2021-2026)
Figure 24. Europe mRNA Flu Vaccine Market Share by Application (2021-2026)
Figure 25. China mRNA Flu Vaccine Market Share by Type (2021-2026)
Figure 26. China mRNA Flu Vaccine Market Share by Application (2021-2026)
Figure 27. Japan mRNA Flu Vaccine Market Share by Type (2021-2026)
Figure 28. Japan mRNA Flu Vaccine Market Share by Application (2021-2026)
Figure 29. Moderna Revenue Growth Rate in mRNA Flu Vaccine Business (2021-2026)
Figure 30. BioNTech Revenue Growth Rate in mRNA Flu Vaccine Business (2021-2026)
Figure 31. Sanofi Revenue Growth Rate in mRNA Flu Vaccine Business (2021-2026)
Figure 32. Curevac Revenue Growth Rate in mRNA Flu Vaccine Business (2021-2026)
Figure 33. Pfizer Revenue Growth Rate in mRNA Flu Vaccine Business (2021-2026)
Figure 34. Arcturus Therapeutics Holdings Revenue Growth Rate in mRNA Flu Vaccine Business (2021-2026)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed